Sorensen Benny 4
4 · Codiak BioSciences, Inc. · Filed Sep 28, 2021
Insider Transaction Report
Form 4
Sorensen Benny
See Remarks
Transactions
- Sale
Common Stock
2021-06-08$26.06/sh−1,640$42,740→ 0 total - Sale
Common Stock
2021-06-08$25.57/sh−6,893$176,276→ 1,640 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-08+8,533→ 87,411 totalExercise: $3.29Exp: 2026-10-24→ Common Stock (8,533 underlying) - Exercise/Conversion
Common Stock
2021-06-08$3.29/sh+8,533$28,074→ 8,533 total
Footnotes (5)
- [F1]The transactions reported in this Form 4 were inadvertently reported late due to an administrative oversight related to communications of the transactions.
- [F2]The sales reported in this Form 4 were effected pursuant to a previously adopted Rule 10b5-1 trading plan.
- [F3]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $25.00 to $25.99 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F4]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $26.00 to $26.13 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F5]The shares underlying this option are fully vested.